May 23, 2017

Saint Luke's Health System will broaden its cancer clinical trials through an affiliation with Washington University in St. Louis.

"It expands the number and the breadth of the available trials that we will be able to offer to our patients here," said Dr. Timothy Pluard, director of Saint Luke's Cancer Institute. "It essentially for us is about tripling the number of NCI clinical trials that we'll have access to."

Read more from the Kansas City Star, here. 

Read more from the Kansas City Business Journal, here. 

Watch it on FOX4 below. 


Watch it on KSHB below. 


Related Content

Kansas City Business Journal: Clinical Trials Deliver a Real Dose of Hope to Cancer Patients
Kansas City Business Journal healthcare reporter examines clinical trial options for cancer patients in Kansas City and interviews Dr. Tim Pluard, Saint Luke's Cancer Institute Medical Director.

Timothy J Pluard, MD

Oncology / Hematology